Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Annual Review of Pathology|April 30, 2009
Molecular pathogenesis of cutaneous melanocytic neoplasmsNageatte Ibrahim, Frank G HaluskaJournal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathwaysSixun Yang, Frank G HaluskaCurrent Oncology Reports|August 12, 2006
Therapeutic targets in melanoma: map kinase pathwayFrank G Haluska, Nageatte IbrahimExpert Review of Anticancer Therapy|May 12, 2007
Novel inhibitors in the treatment of metastatic melanomaKevin Kalinsky, Frank G HaluskaJournal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR aviditySixun Yang, Gerald P Linette, Simonne Longerich, et al.The Journal of Investigative Dermatology|March 11, 2004
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanomaHensin Tsao, Vikas Goel, Heng Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Genetic alterations in signaling pathways in melanomaFrank G Haluska, Hensin Tsao, Helen Wu, et al.American Journal of Clinical Oncology|June 1, 2002
Phase II study of paclitaxel and carboplatin for malignant melanomaF Stephen Hodi, Robert J Soiffer, Jeffrey Clark, et al.The Journal of Investigative Dermatology|January 19, 2006
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanomaVikas K Goel, Alexander J F Lazar, Carla L Warneke, et al.Pageof 4